Cellectis - M&A Summary and Business Overview

Life ScienceCompany

Cellectis M&A Summary

Cellectis has acquired 3 companies. It has also divested 1 asset.

Cellectis’ largest acquisition to date was in 2010, when it acquired Cyto Pulse Sciences for $2M. Cellectis has acquired in 1 US state, and 3 countries. The Company’s most targeted sectors include medical products (67%) and life science (34%).

Cellectis Business Overview

Where is Cellectis headquartered?

Cellectis is headquartered in Paris, France.

What is Cellectis’ revenue?

Cellectis disclosed revenue of 50M EUR for 2015 and 22M EUR for 2014.

How many employees does Cellectis have?

Cellectis has 203 employees.

What sector is Cellectis in?

Cellectis is a life science company.

When was Cellectis founded?

Cellectis was founded in 1999.

M&A Summary

  • M&A Total Activity4
    • M&A Buy Activity3
    • M&A Sell Activity1
  • Total Sectors Invested 2
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 2

Cellectis

Cellectis S.A.

8 rue de la Croix Jarry,
Paris, 75013
France,
+33 1 81 69 16 00
www.cellectis.com

Cellectis is a gene-editing company focused on developing immunotherapies based on gene edited engineered CAR-T cells (UCART). Cellectis was founded in 1999 and is based in Paris, France.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 3 - - - - - 3
vol $2M $2M
Sell (0.0/yr) # 1 - - - - - 1
  4

Most Recent M&A

Company Date Value Type
Cellectis AB 2014-07-29 - Divestiture
Gothenburg, Sweden
Cellartis AB 2011-11-04 - Add-on Acquisition
Gothenburg,, Sweden · www.cellartis.com
Cyto Pulse Sciences Inc. 2010-09-09 2M USD Add-on Acquisition
Glen Burnie, Maryland
Diatos - Vectocell Technology 2009-10-12 - Divestiture
, France
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Medical Products 2 (67%) 2M (100%) - -
Life Science 1 (33%) - 1 (100%) -
Total 3 $2M 1 -

By Geo

State/Country Buy Value Sell Value
Sweden 1 - 1 -
France 1 - - -
United States 1 2M - -
  Maryland 1 2M - -
Domestic 1 (33%) - - -
Cross-border 2 (67%) 2M (100%) 1 (100%) -
Total 3 $2M 1 -

Deal Values

buy # Total
< $100M 1 $2M
TOTAL $2M
Largest Cyto Pulse Sciences Inc.
$2M (2010-09-09)

M&A Connections

Deals
Acquired from
Strategic(s)
33%
1 (33%)
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Cellectis

Life Science Companies , France Companies